The Wilms Tumor Suppressor-1 Target Gene Podocalyxin Is Transcriptionally Repressed by p53
Open Access
- 1 August 2004
- journal article
- Published by Elsevier
- Vol. 279 (32), 33575-33585
- https://doi.org/10.1074/jbc.m404787200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The p53 Stabilizing Compound CP-31398 Induces Apoptosis by Activating the Intrinsic Bax/Mitochondrial/Caspase-9 PathwayExperimental Cell Research, 2002
- Relative frequency and morphology of cancers in carriers of germline TP53 mutationsOncogene, 2001
- Phenotypic modulation of parietal epithelial cells of Bowman's capsule in cultureCell and tissue research, 2001
- Identification of Connective Tissue Growth Factor as a Target of WT1 Transcriptional RegulationJournal of Biological Chemistry, 2000
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Regulation ofp53downstream genesSeminars in Cancer Biology, 1998
- Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymeraseOncogene, 1997
- Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutationsNature Genetics, 1994
- Wilms' tumor in the Li-Fraumeni cancer family syndromeCancer Genetics and Cytogenetics, 1993
- Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell.The Journal of cell biology, 1984